News and Updates

A new clinical study reveals that the probiotic Lactiplantibacillus plantarum KABP051 improves metabolic markers and boosts mood through the gut-brain axis.

UniQure is moving toward FDA approval for its Huntington’s gene therapy, AMT-130, following a major regulatory breakthrough in treating the rare condition.

A landmark global trial identifies a safer antibiotic standard for Staph aureus bloodstream infections, significantly reducing complications and risks.

Explore the 2026 DPN pipeline. Discover how Helixmith, Lexicon, and others are developing breakthrough therapies to treat diabetic peripheral neuropathy.

Global biotech collaboration faces risks from trade barriers. Discover how restricting international partnerships could stall life-saving medical innovation.

New global clinical trial findings identify the safest, most effective antibiotic treatments for Staphylococcus aureus bloodstream infections.

The FDA has approved the first oral carbapenem for complicated UTIs. Discover how this shift in antibiotic delivery impacts patient care and resistance.

Discover the hidden dangers of the booming black market for GLP-1 weight loss drugs. Learn why counterfeit injections pose severe risks to patient safety.

ADC Therapeutics pauses Zynlonta clinical trials following patient deaths. Learn about the safety concerns surrounding this CD19-targeted cancer therapy.

New research confirms AI now matches or exceeds physician performance in diagnostics. Discover how machine learning is redefining the future of patient care.